DelveInsight Blog

Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm On March 21, 2023, Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced it had received U.S. Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA). Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected AAA. Viz AAA uses artificial intelligence to automatically search for the presence of an abdominal aortic aneurysm from computed tomography angiography (CTA)…

Triglycerides, the energy-providing lipids consumed from fat-containing food, have been known to cause severe health conditions in high levels, including acute pancreatitis. It is also associated with apolipoprotein C-III (APOCIII) and high probability of coronary artery disease (CAD). Triglyceride levels above a certain level are termed as severe hypertriglyceridemia (sHTG). Elevated triglycerides may also result from genetic factors, Familial chylomicronemia syndrome (FCS) is one such disorder.   What are APOC III Inhibitors? Long-recognized APOC III is a small protein that functions as a key regulator of triglyceride metabolism by inhibiting lipoprotein…

With the onset of the fourth industrial revolution in the twenty-first century, a new branch emerged: Robotics. Robotics is the amalgam of computer science and engineering to make programmable machines that aim to assist humans in their tasks and produce results with minimum error. From space science to healthcare to hospitality, the usage of robots is being explored in every industry. Recent disruptive technologies such as 5G and artificial intelligence only fuel the healthcare market. With the following article, we will try to understand the use of robotics in surgeries…